See more : Türkiye Sinai Kalkinma Bankasi A.S. (TRKYY) Income Statement Analysis – Financial Results
Complete financial analysis of Valbiotis SA (ALVAL.PA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Valbiotis SA, a leading company in the Biotechnology industry within the Healthcare sector.
- RFHIC Corporation (218410.KQ) Income Statement Analysis – Financial Results
- DiDi Global Inc. (DIDI) Income Statement Analysis – Financial Results
- LEVERAGE SHARES PUBLIC LIMITED (1ARW.L) Income Statement Analysis – Financial Results
- Star Paper Mills Limited (STARPAPER.BO) Income Statement Analysis – Financial Results
- RTX Corporation (RTX.BA) Income Statement Analysis – Financial Results
Valbiotis SA (ALVAL.PA)
About Valbiotis SA
Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with non-alcoholic fatty liver disease. It has a strategic partnership with Nestlé Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in Périgny, France.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.73M | 785.00K | 298.00K | 3.09M | 91.00K | 79.00K | 3.00K | 646.00K | 10.00K |
| Cost of Revenue | 2.04M | 18.00K | 16.00K | 4.00K | 17.00K | 398.00K | 69.00K | 26.00K | 38.00K |
| Gross Profit | 2.69M | 767.00K | 282.00K | 3.09M | 74.00K | -319.00K | -66.00K | 620.00K | -28.00K |
| Gross Profit Ratio | 56.81% | 97.71% | 94.63% | 99.87% | 81.32% | -403.80% | -2,200.00% | 95.98% | -280.00% |
| Research & Development | 7.15M | 8.36M | 6.18M | 4.54M | 3.20M | 3.83M | 1.65M | 788.00K | 705.00K |
| General & Administrative | 2.16M | 1.65M | 1.12M | 1.37M | 1.30M | 1.25M | 822.00K | 252.00K | 0.00 |
| Selling & Marketing | 2.02M | 1.70M | 1.51M | 1.02M | 1.47M | 1.06M | 533.00K | 183.00K | 0.00 |
| SG&A | 4.18M | 5.64M | 3.98M | 2.97M | 2.94M | 2.53M | 1.52M | 435.00K | 358.00K |
| Other Expenses | 2.70M | -40.00K | -70.00K | 0.00 | -2.00K | 5.00K | 2.00K | -5.00K | 136.00K |
| Operating Expenses | 9.87M | 14.04M | 10.23M | 7.50M | 6.15M | 4.96M | 2.37M | 1.22M | 927.00K |
| Cost & Expenses | 11.91M | 14.84M | 11.17M | 8.51M | 7.07M | 4.96M | 2.37M | 1.22M | 965.00K |
| Interest Income | 33.00K | 227.00K | 229.00K | 421.00K | 358.00K | 83.00K | 76.00K | 23.00K | 4.25K |
| Interest Expense | 221.00K | 287.00K | 348.00K | 421.00K | 358.00K | 83.00K | 76.00K | 23.00K | 20.00K |
| Depreciation & Amortization | 736.00K | 802.00K | 941.00K | 1.00M | 922.00K | 187.00K | 69.00K | 26.00K | 38.00K |
| EBITDA | -6.41M | -11.13M | -7.47M | -2.37M | -4.22M | -4.53M | -2.33M | -882.00K | -908.00K |
| EBITDA Ratio | -135.45% | -1,688.28% | -3,332.21% | -142.69% | -6,656.04% | -5,735.44% | -77,733.33% | -84.67% | -9,170.00% |
| Operating Income | -7.16M | -14.06M | -10.87M | -5.41M | -6.98M | -4.79M | -2.40M | -572.00K | -955.00K |
| Operating Income Ratio | -151.28% | -1,790.45% | -3,647.99% | -175.10% | -7,669.23% | -6,060.76% | -80,033.33% | -88.54% | -9,550.00% |
| Total Other Income/Expenses | -2.24M | -2.22M | -2.03M | -1.68M | -1.57M | -179.00K | -42.00K | -16.00K | -11.00K |
| Income Before Tax | -9.40M | -14.20M | -10.43M | -5.09M | -6.72M | -4.97M | -2.44M | -593.00K | -966.00K |
| Income Before Tax Ratio | -198.52% | -1,809.43% | -3,500.34% | -164.49% | -7,389.01% | -6,287.34% | -81,433.33% | -91.80% | -9,660.00% |
| Income Tax Expense | -2.03M | -1.89M | -1.75M | -1.26M | -1.22M | -1.18M | -474.00K | 21.00K | -227.00K |
| Net Income | -7.37M | -12.31M | -8.68M | -3.83M | -5.50M | -4.97M | -2.44M | -593.00K | -739.00K |
| Net Income Ratio | -155.67% | -1,568.41% | -2,913.09% | -123.84% | -6,048.35% | -6,287.34% | -81,433.33% | -91.80% | -7,390.00% |
| EPS | -0.59 | -1.22 | -0.95 | -0.51 | -1.17 | -1.32 | -0.92 | -0.17 | -60.73 |
| EPS Diluted | -0.59 | -1.22 | -0.95 | -0.51 | -1.17 | -1.32 | -0.92 | -0.17 | -60.73 |
| Weighted Avg Shares Out | 12.46M | 10.11M | 9.16M | 7.45M | 4.70M | 3.77M | 2.64M | 3.58M | 12.17K |
| Weighted Avg Shares Out (Dil) | 12.46M | 10.11M | 9.16M | 7.45M | 4.70M | 3.77M | 2.64M | 3.58M | 12.17K |
Source: https://incomestatements.info
Category: Stock Reports